Apyx Medical Corporation (APYX) financial statements (2020 and earlier)

Company profile

Business Address 5115 ULMERTON ROAD
CLEARWATER, FL 33760
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments627810141268
Cash and cash equivalents621610141268
Short-term investments 62     
Receivables8555322
Inventory, net of allowances, customer advances and progress billings7576668
Inventory7576668
Deposits current assets     01
Other undisclosed current assets2111121
Total current assets:79902327221520
Noncurrent Assets
Finance lease, right-of-use asset1
Operating lease, right-of-use asset0
Property, plant and equipment7666777
Intangible assets, net (including goodwill) 022201
Goodwill 0000  
Intangible assets, net (excluding goodwill) 022201
Deposits noncurrent assets 000000
Other noncurrent assets0000001
Other undisclosed noncurrent assets    025
Total noncurrent assets:86899913
TOTAL ASSETS:87963135312533
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9545432
Accounts payable1122121
Accrued liabilities7323221
Employee-related liabilities 1111  
Debt0 00000
Other undisclosed current liabilities 21  01
Total current liabilities:9865443
Noncurrent Liabilities
Long-term debt and lease obligation1023333
Long-term debt, excluding current maturities0023333
Finance lease, liability0
Operating lease, liability0
Liabilities, other than long-term debt0 0000 
Deferred revenue and credits 000 
Deferred revenue0
Derivative instruments and hedges, liabilities  00   
Other undisclosed noncurrent liabilities  111136
Total noncurrent liabilities:10344169
Total liabilities:1089982012
Stockholders' equity
Stockholders' equity attributable to parent, including:7788222623219
Preferred stock   0   
Common stock0000000
Additional paid in capital56525050432929
Retained earnings (accumulated deficit)2136(28)(23)(19)(28)(10)
Other undisclosed stockholders' equity attributable to parent    0  
Other undisclosed stockholders' equity     32
Total stockholders' equity:7788222623521
TOTAL LIABILITIES AND EQUITY:87963135312533

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues26173937302824
Revenue, net6173937302824
Cost of revenue
(Cost of Goods and Services Sold)
(9)(6)(19)(19)(17)(19)(14)
Gross profit:171120181399
Operating expenses(36)(24)(25)(22)(20)(23)(21)
Other operating expense, net(0)(0)     
Other undisclosed operating income00   88
Operating loss:(20)(14)(5)(4)(7)(6)(4)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
200(0)2(7)(2)
Interest and debt expense (0)     
Other undisclosed loss from continuing operations before equity method investments, income taxes(0)      
Loss from continuing operations before equity method investments, income taxes:(18)(13)(5)(4)(5)(13)(6)
Other undisclosed income from continuing operations before income taxes00     
Loss from continuing operations before income taxes:(18)(13)(5)(4)(5)(13)(6)
Income tax expense (benefit)140(0)(0)(4)(2)
Net loss:(17)(9)(5)(4)(5)(17)(8)
Other undisclosed net income attributable to parent      3
Net loss attributable to parent:(17)(9)(5)(4)(5)(17)(4)
Other undisclosed net income (loss) available to common stockholders, basic(1)74  14(1) 
Net income (loss) available to common stockholders, basic:(17)64(5)(4)8(18)(4)
Convertible preferred dividends    11,061 
Other undisclosed net loss available to common stockholders, diluted  (0)(0)(3)  
Net income (loss) available to common stockholders, diluted:(17)64(5)(4)71,042(4)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(17)(9)(5)(4)(5)(17)(8)
Comprehensive loss, net of tax, attributable to parent:(17)(9)(5)(4)(5)(17)(8)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: